📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effects of cannabidiol on symptoms in people at clinical high risk for psychosis. (2024)

First Author: Bhattacharyya S

Attributed to: CANNABIDIOL AS A NOVEL THERAPEUTIC AGENT FOR PATIENTS AT ULTRA HIGH-RISK OF PSYCHOSIS: AN EXPERIMENTAL MEDICINE APPROACH funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/wps.21253

PubMed Identifier: 39279373

Publication URI: http://europepmc.org/abstract/MED/39279373

Type: Journal Article/Review

Volume: 23

Parent Publication: World psychiatry : official journal of the World Psychiatric Association (WPA)

Issue: 3

ISSN: 1723-8617